375 related articles for article (PubMed ID: 23873778)
1. Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation.
Musat AI; Pigott CM; Ellis TM; Agni RM; Leverson GE; Powell AJ; Richards KR; D'Alessandro AM; Lucey MR
Liver Transpl; 2013 Oct; 19(10):1132-41. PubMed ID: 23873778
[TBL] [Abstract][Full Text] [Related]
2. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Beltran Catalan S; Avila Bernabeu A; Crespo Albiach J; Montoro JA; Pallardo Mateu LM
Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
[TBL] [Abstract][Full Text] [Related]
3. Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation.
O'Leary JG; Kaneku H; Jennings LW; Bañuelos N; Susskind BM; Terasaki PI; Klintmalm GB
Liver Transpl; 2013 Sep; 19(9):973-80. PubMed ID: 23780820
[TBL] [Abstract][Full Text] [Related]
4. Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts.
Miyagawa-Hayashino A; Yoshizawa A; Uchida Y; Egawa H; Yurugi K; Masuda S; Minamiguchi S; Maekawa T; Uemoto S; Haga H
Liver Transpl; 2012 Nov; 18(11):1333-42. PubMed ID: 22888064
[TBL] [Abstract][Full Text] [Related]
5. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation with a strongly positive crossmatch: case study and literature review.
Leonard GR; Shike H; Uemura T; Gaspari JL; Ruggiero FM; Shah RA; Riley TR; Kadry Z
Liver Transpl; 2013 Sep; 19(9):1001-10. PubMed ID: 23798324
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
9. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
10. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody.
Higgins R; Hathaway M; Lowe D; Lam F; Kashi H; Tan LC; Imray C; Fletcher S; Zehnder D; Chen K; Krishnan N; Hamer R; Briggs D
Transplantation; 2007 Oct; 84(7):876-84. PubMed ID: 17984841
[TBL] [Abstract][Full Text] [Related]
11. Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation.
Kaneku H; O'Leary JG; Taniguchi M; Susskind BM; Terasaki PI; Klintmalm GB
Liver Transpl; 2012 Aug; 18(8):984-92. PubMed ID: 22508525
[TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature.
Kheradmand T; Anthony TL; Harland RC; Testa G; Hart J; Renz J; Te HS; Marino SR
Hum Immunol; 2014 Jun; 75(6):578-83. PubMed ID: 24530823
[TBL] [Abstract][Full Text] [Related]
13. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
[TBL] [Abstract][Full Text] [Related]
14. C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection.
Hönger G; Wahrmann M; Amico P; Hopfer H; Böhmig GA; Schaub S
Transplantation; 2010 Jun; 89(12):1471-5. PubMed ID: 20395886
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.
O'Leary JG; Kaneku H; Demetris AJ; Marr JD; Shiller SM; Susskind BM; Tillery GW; Terasaki PI; Klintmalm GB
Liver Transpl; 2014 Feb; 20(2):218-27. PubMed ID: 24382837
[TBL] [Abstract][Full Text] [Related]
16. Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantation.
Muro M; Legaz I
World J Gastroenterol; 2023 Feb; 29(5):766-772. PubMed ID: 36816626
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
[TBL] [Abstract][Full Text] [Related]
18. Anti-human leukocyte antigen immunization after early allograft nephrectomy.
Del Bello A; Congy N; Sallusto F; Cardeau-Desangles I; Fort M; Esposito L; Guitard J; Cointault O; Lavayssière L; Nogier MB; Game X; Blancher A; Rostaing L; Kamar N
Transplantation; 2012 May; 93(9):936-41. PubMed ID: 22361471
[TBL] [Abstract][Full Text] [Related]
19. Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure.
Iacob S; Cicinnati VR; Lindemann M; Heinemann FM; Radtke A; Kaiser GM; Kabar I; Schmidt HH; Baba HA; Beckebaum S
Transplantation; 2015 Sep; 99(9):1869-75. PubMed ID: 25706274
[TBL] [Abstract][Full Text] [Related]
20. The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomes.
Wu K; Budde K; Lu H; Schmidt D; Liefeldt L; Glander P; Neumayer HH; Rudolph B
Transplantation; 2014 Jun; 97(11):1146-54. PubMed ID: 24892962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
